| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.579 | 0.008 | 0.678 | Calcium channel L-type activator | 0.416 0.071 DBMET03325 0.404 0.079 DBMET03326 0.433 0.06 DBMET03328 0.579 0.008 DBMET03330 0.678 0.003 DBMET03332 0.5 0.028 DBMET03324 0.579 0.008 DBMET03331 0.678 0.003 DBMET03333 0.678 0.003 DBMET03334 | DBMET03334 | |
| 0.572 | 0.002 | 0.572 | Adrenaline agonist | 0.123 0.024 DBMET03326 0.131 0.021 DBMET03328 0.572 0.002 DBMET03330 0.492 0.002 DBMET03332 0.198 0.007 DBMET03324 0.572 0.002 DBMET03331 0.492 0.002 DBMET03333 0.492 0.002 DBMET03334 | ||
| 0.552 | 0.001 | 0.552 | Beta 3 adrenoreceptor agonist | 0.016 0.005 DBMET03326 0.014 0.006 DBMET03328 0.552 0.001 DBMET03330 0.229 0.002 DBMET03332 0.035 0.004 DBMET03324 0.552 0.001 DBMET03331 0.229 0.002 DBMET03333 0.229 0.002 DBMET03334 | ||
| 0.55 | 0.028 | 0.685 | Antiobesity | 0.293 0.121 DBMET03326 0.3 0.116 DBMET03328 0.55 0.028 DBMET03330 0.685 0.012 DBMET03332 0.229 0.178 DBMET03324 0.55 0.028 DBMET03331 0.685 0.012 DBMET03333 0.685 0.012 DBMET03334 | DBMET03334 | |
| 0.528 | 0.017 | 0.528 | Calpain 2 inhibitor | 0.528 0.017 DBMET03330 0.401 0.061 DBMET03332 0.528 0.017 DBMET03331 0.401 0.061 DBMET03333 0.401 0.061 DBMET03334 | ||
| 0.528 | 0.043 | 0.655 | Cyclophilin D inhibitor | 0.444 0.069 DBMET03325 0.624 0.023 DBMET03326 0.63 0.022 DBMET03328 0.495 0.052 DBMET03329 0.528 0.043 DBMET03330 0.557 0.036 DBMET03332 0.655 0.019 DBMET03324 0.528 0.043 DBMET03331 0.557 0.036 DBMET03333 0.557 0.036 DBMET03334 | DBMET03324 | |
| 0.472 | 0.001 | 0.472 | Beta adrenoreceptor agonist | 0.061 0.008 DBMET03326 0.065 0.006 DBMET03328 0.472 0.001 DBMET03330 0.315 0.002 DBMET03332 0.077 0.005 DBMET03324 0.472 0.001 DBMET03331 0.315 0.002 DBMET03333 0.315 0.002 DBMET03334 | ||
| 0.468 | 0.05 | 0.72 | Antibacterial | 0.611 0.018 DBMET03325 0.72 0.007 DBMET03326 0.69 0.009 DBMET03328 0.653 0.013 DBMET03329 0.468 0.05 DBMET03330 0.247 0.18 DBMET03332 0.54 0.031 DBMET03324 0.468 0.05 DBMET03331 0.247 0.18 DBMET03333 0.247 0.18 DBMET03334 | DBMET03326 | |
| 0.388 | 0.006 | 0.857 | Bronchodilator | 0.098 0.067 DBMET03326 0.388 0.006 DBMET03330 0.857 0.003 DBMET03332 0.202 0.018 DBMET03324 0.388 0.006 DBMET03331 0.857 0.003 DBMET03333 0.857 0.003 DBMET03334 | DBMET03334 | |
| 0.36 | 0.007 | 0.465 | Cell wall synthesis inhibitor | 0.447 0.005 DBMET03325 0.461 0.004 DBMET03326 0.465 0.004 DBMET03328 0.386 0.006 DBMET03329 0.36 0.007 DBMET03330 0.13 0.086 DBMET03332 0.205 0.028 DBMET03324 0.36 0.007 DBMET03331 0.13 0.086 DBMET03333 0.13 0.086 DBMET03334 | DBMET03328 | |
| 0.34 | 0.01 | 0.345 | Insulin sensitizer | 0.158 0.123 DBMET03325 0.24 0.04 DBMET03326 0.21 0.064 DBMET03328 0.169 0.108 DBMET03329 0.34 0.01 DBMET03330 0.345 0.01 DBMET03332 0.226 0.05 DBMET03324 0.34 0.01 DBMET03331 0.345 0.01 DBMET03333 0.345 0.01 DBMET03334 | DBMET03334 | |
| 0.3 | 0.003 | 0.361 | Beta 2 adrenoreceptor antagonist | 0.3 0.003 DBMET03330 0.361 0.002 DBMET03332 0.047 0.041 DBMET03324 0.3 0.003 DBMET03331 0.361 0.002 DBMET03333 0.361 0.002 DBMET03334 | DBMET03334 | |
| 0.295 | 0.003 | 0.295 | Beta 1 adrenoreceptor antagonist | 0.295 0.003 DBMET03330 0.291 0.003 DBMET03332 0.295 0.003 DBMET03331 0.291 0.003 DBMET03333 0.291 0.003 DBMET03334 | ||
| 0.278 | 0.009 | 0.278 | Antibacterial (Helicobacter pylori) | 0.113 0.092 DBMET03325 0.156 0.041 DBMET03326 0.138 0.058 DBMET03328 0.111 0.096 DBMET03329 0.278 0.009 DBMET03330 0.278 0.009 DBMET03331 | ||
| 0.292 | 0.028 | 0.367 | Peptidyltransferase inhibitor | 0.332 0.015 DBMET03325 0.361 0.01 DBMET03326 0.33 0.016 DBMET03328 0.287 0.03 DBMET03329 0.292 0.028 DBMET03330 0.367 0.01 DBMET03332 0.326 0.017 DBMET03324 0.292 0.028 DBMET03331 0.367 0.01 DBMET03333 0.367 0.01 DBMET03334 | DBMET03334 | |
| 0.279 | 0.015 | 0.746 | Antiadrenergic | 0.279 0.015 DBMET03330 0.746 0.004 DBMET03332 0.279 0.015 DBMET03331 0.746 0.004 DBMET03333 0.746 0.004 DBMET03334 | DBMET03334 | |
| 0.341 | 0.086 | 0.678 | Toll-Like receptor 7 agonist | 0.341 0.086 DBMET03330 0.678 0.01 DBMET03332 0.341 0.086 DBMET03331 0.678 0.01 DBMET03333 0.678 0.01 DBMET03334 | DBMET03334 | |
| 0.27 | 0.015 | 0.744 | Adrenaline antagonist | 0.27 0.015 DBMET03330 0.744 0.004 DBMET03332 0.27 0.015 DBMET03331 0.744 0.004 DBMET03333 0.744 0.004 DBMET03334 | DBMET03334 | |
| 0.339 | 0.088 | 0.677 | Toll-Like receptor agonist | 0.339 0.088 DBMET03330 0.677 0.01 DBMET03332 0.339 0.088 DBMET03331 0.677 0.01 DBMET03333 0.677 0.01 DBMET03334 | DBMET03334 | |
| 0.284 | 0.038 | 0.284 | Calpain inhibitor | 0.284 0.038 DBMET03330 0.266 0.051 DBMET03332 0.284 0.038 DBMET03331 0.266 0.051 DBMET03333 0.266 0.051 DBMET03334 | ||
| 0.211 | 0.004 | 0.303 | Beta adrenoreceptor antagonist | 0.211 0.004 DBMET03330 0.303 0.003 DBMET03332 0.211 0.004 DBMET03331 0.303 0.003 DBMET03333 0.303 0.003 DBMET03334 | DBMET03334 | |
| 0.238 | 0.037 | 0.238 | Growth factor agonist | 0.148 0.146 DBMET03325 0.185 0.08 DBMET03326 0.159 0.121 DBMET03328 0.194 0.069 DBMET03329 0.238 0.037 DBMET03330 0.238 0.037 DBMET03331 | ||
| 0.188 | 0.012 | 0.188 | Nitric-oxide synthase inhibitor | 0.188 0.012 DBMET03330 0.187 0.012 DBMET03332 0.188 0.012 DBMET03331 0.187 0.012 DBMET03333 0.187 0.012 DBMET03334 | ||
| 0.198 | 0.037 | 0.251 | Insulin secretagoues | 0.179 0.049 DBMET03325 0.251 0.019 DBMET03326 0.218 0.028 DBMET03328 0.202 0.035 DBMET03329 0.198 0.037 DBMET03330 0.181 0.047 DBMET03332 0.211 0.03 DBMET03324 0.198 0.037 DBMET03331 0.181 0.047 DBMET03333 0.181 0.047 DBMET03334 | DBMET03326 | |
| 0.312 | 0.156 | 0.312 | DNA directed DNA polymerase inhibitor | 0.312 0.156 DBMET03330 0.312 0.156 DBMET03331 | ||
| 0.19 | 0.037 | 0.19 | M18 aspartyl aminopeptidase inhibitor | 0.19 0.037 DBMET03330 0.173 0.043 DBMET03332 0.19 0.037 DBMET03331 0.173 0.043 DBMET03333 0.173 0.043 DBMET03334 | ||
| 0.177 | 0.031 | 0.34 | Adenylate cyclase inhibitor | 0.177 0.031 DBMET03330 0.34 0.01 DBMET03332 0.177 0.031 DBMET03331 0.34 0.01 DBMET03333 0.34 0.01 DBMET03334 | DBMET03334 | |
| 0.148 | 0.006 | 0.356 | Beta 3 adrenoreceptor antagonist | 0.148 0.006 DBMET03330 0.356 0.002 DBMET03332 0.148 0.006 DBMET03331 0.356 0.002 DBMET03333 0.356 0.002 DBMET03334 | DBMET03334 | |
| 0.142 | 0.003 | 0.214 | Beta 2 adrenoreceptor agonist | 0.142 0.003 DBMET03330 0.214 0.002 DBMET03332 0.062 0.043 DBMET03324 0.142 0.003 DBMET03331 0.214 0.002 DBMET03333 0.214 0.002 DBMET03334 | DBMET03334 | |
| 0.147 | 0.01 | 0.147 | Histamine H2 receptor antagonist | 0.147 0.01 DBMET03330 0.12 0.021 DBMET03332 0.147 0.01 DBMET03331 0.12 0.021 DBMET03333 0.12 0.021 DBMET03334 | ||
| 0.137 | 0.012 | 0.156 | Carbonic anhydrase stimulant | 0.137 0.012 DBMET03330 0.156 0.01 DBMET03332 0.137 0.012 DBMET03331 0.156 0.01 DBMET03333 0.156 0.01 DBMET03334 | DBMET03334 | |
| 0.124 | 0.004 | 0.124 | Diamine oxidase inhibitor | 0.124 0.004 DBMET03330 0.12 0.004 DBMET03332 0.124 0.004 DBMET03331 0.12 0.004 DBMET03333 0.12 0.004 DBMET03334 | ||
| 0.236 | 0.135 | 0.404 | Interleukin 2 agonist | 0.359 0.042 DBMET03325 0.404 0.026 DBMET03326 0.395 0.029 DBMET03328 0.372 0.037 DBMET03329 0.236 0.135 DBMET03330 0.397 0.028 DBMET03332 0.258 0.11 DBMET03324 0.236 0.135 DBMET03331 0.397 0.028 DBMET03333 0.397 0.028 DBMET03334 | DBMET03326 | |
| 0.099 | 0.007 | 0.099 | Stearoyl-CoA desaturase inhibitor | 0.099 0.007 DBMET03330 0.055 0.02 DBMET03332 0.099 0.007 DBMET03331 0.055 0.02 DBMET03333 0.055 0.02 DBMET03334 | ||
| 0.218 | 0.132 | 0.218 | 12-Lipoxygenase inhibitor | 0.218 0.132 DBMET03330 0.218 0.132 DBMET03331 | ||
| 0.101 | 0.018 | 0.101 | Secretase beta inhibitor | 0.101 0.018 DBMET03330 0.085 0.03 DBMET03332 0.101 0.018 DBMET03331 0.085 0.03 DBMET03333 0.085 0.03 DBMET03334 | ||
| 0.098 | 0.028 | 0.108 | Carbonic anhydrase V inhibitor | 0.098 0.028 DBMET03330 0.108 0.024 DBMET03332 0.098 0.028 DBMET03331 0.108 0.024 DBMET03333 0.108 0.024 DBMET03334 | DBMET03334 | |
| 0.116 | 0.046 | 0.116 | Gastric antisecretory | 0.116 0.046 DBMET03330 0.105 0.059 DBMET03332 0.116 0.046 DBMET03331 0.105 0.059 DBMET03333 0.105 0.059 DBMET03334 | ||
| 0.072 | 0.003 | 0.171 | Beta 1 adrenoreceptor agonist | 0.072 0.003 DBMET03330 0.171 0.002 DBMET03332 0.072 0.003 DBMET03331 0.171 0.002 DBMET03333 0.171 0.002 DBMET03334 | DBMET03334 | |
| 0.107 | 0.039 | 0.187 | Aminoacyl-tRNA synthetase inhibitor | 0.107 0.039 DBMET03330 0.187 0.012 DBMET03332 0.098 0.048 DBMET03324 0.107 0.039 DBMET03331 0.187 0.012 DBMET03333 0.187 0.012 DBMET03334 | DBMET03334 | |
| 0.095 | 0.027 | 0.097 | Carbonic anhydrase VA inhibitor | 0.095 0.027 DBMET03330 0.097 0.026 DBMET03332 0.095 0.027 DBMET03331 0.097 0.026 DBMET03333 0.097 0.026 DBMET03334 | DBMET03334 | |
| 0.073 | 0.009 | 0.075 | Immunoglobulin Fc receptor antagonist | 0.073 0.009 DBMET03330 0.075 0.008 DBMET03332 0.073 0.009 DBMET03331 0.075 0.008 DBMET03333 0.075 0.008 DBMET03334 | DBMET03334 | |
| 0.072 | 0.009 | 0.072 | Histamine H2 receptor agonist | 0.072 0.009 DBMET03330 0.059 0.015 DBMET03332 0.072 0.009 DBMET03331 0.059 0.015 DBMET03333 0.059 0.015 DBMET03334 | ||
| 0.066 | 0.013 | 0.066 | Carnitine palmitoyltransferase 1B inhibitor | 0.047 0.035 DBMET03325 0.05 0.029 DBMET03326 0.045 0.039 DBMET03328 0.047 0.034 DBMET03329 0.066 0.013 DBMET03330 0.052 0.026 DBMET03324 0.066 0.013 DBMET03331 | ||
| 0.075 | 0.025 | 0.096 | Carbonic anhydrase VB inhibitor | 0.075 0.025 DBMET03330 0.096 0.017 DBMET03332 0.075 0.025 DBMET03331 0.096 0.017 DBMET03333 0.096 0.017 DBMET03334 | DBMET03334 | |
| 0.065 | 0.021 | 0.065 | DNA helicase inhibitor | 0.05 0.049 DBMET03325 0.056 0.035 DBMET03326 0.053 0.04 DBMET03329 0.065 0.021 DBMET03330 0.065 0.021 DBMET03331 | ||
| 0.135 | 0.092 | 0.31 | Adenylate cyclase stimulant | 0.135 0.092 DBMET03330 0.31 0.003 DBMET03332 0.135 0.092 DBMET03331 0.31 0.003 DBMET03333 0.31 0.003 DBMET03334 | DBMET03334 | |
| 0.075 | 0.042 | 0.454 | Phenylalanine 4-hydroxylase inhibitor | 0.075 0.042 DBMET03330 0.454 0.003 DBMET03332 0.075 0.042 DBMET03331 0.454 0.003 DBMET03333 0.454 0.003 DBMET03334 | DBMET03334 | |
| 0.042 | 0.01 | 0.042 | Methionyl aminopeptidase 1 inhibitor | 0.042 0.01 DBMET03330 0.032 0.023 DBMET03332 0.042 0.01 DBMET03331 0.032 0.023 DBMET03333 0.032 0.023 DBMET03334 | ||
| 0.064 | 0.037 | 0.281 | Acetylcholine M3 receptor antagonist | 0.064 0.037 DBMET03330 0.281 0.004 DBMET03332 0.064 0.037 DBMET03331 0.281 0.004 DBMET03333 0.281 0.004 DBMET03334 | DBMET03334 | |
| 0.066 | 0.04 | 0.097 | Neuraminidase (influenza) inhibitor | 0.077 0.028 DBMET03325 0.084 0.023 DBMET03326 0.097 0.017 DBMET03328 0.08 0.025 DBMET03329 0.066 0.04 DBMET03330 0.063 0.047 DBMET03332 0.068 0.038 DBMET03324 0.066 0.04 DBMET03331 0.063 0.047 DBMET03333 0.063 0.047 DBMET03334 | DBMET03328 | |
| 0.081 | 0.059 | 0.094 | Protein kinase A inhibitor | 0.094 0.049 DBMET03326 0.081 0.059 DBMET03330 0.081 0.059 DBMET03331 | DBMET03326 | |
| 0.08 | 0.061 | 0.123 | Inducible nitric-oxide synthase inhibitor | 0.08 0.061 DBMET03330 0.123 0.024 DBMET03332 0.08 0.061 DBMET03331 0.123 0.024 DBMET03333 0.123 0.024 DBMET03334 | DBMET03334 | |
| 0.056 | 0.046 | 0.056 | Sphingosine kinase inhibitor | 0.056 0.046 DBMET03330 0.054 0.051 DBMET03332 0.056 0.046 DBMET03331 0.054 0.051 DBMET03333 0.054 0.051 DBMET03334 | ||
| 0.206 | 0.204 | 0.489 | Calcium channel activator | 0.206 0.204 DBMET03330 0.489 0.005 DBMET03332 0.206 0.204 DBMET03331 0.489 0.005 DBMET03333 0.489 0.005 DBMET03334 | DBMET03334 | |
| 0.028 | 0.026 | 0.058 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.026 DBMET03330 0.058 0.008 DBMET03332 0.028 0.026 DBMET03331 0.058 0.008 DBMET03333 0.058 0.008 DBMET03334 | DBMET03334 | |
| 0.047 | 0.046 | 0.117 | Maillard reaction inhibitor | 0.047 0.046 DBMET03330 0.117 0.011 DBMET03332 0.047 0.046 DBMET03331 0.117 0.011 DBMET03333 0.117 0.011 DBMET03334 | DBMET03334 | |
| 0.16 | 0.163 | 0.402 | Hypoglycemic | 0.312 0.049 DBMET03325 0.397 0.028 DBMET03326 0.402 0.027 DBMET03328 0.399 0.028 DBMET03329 0.24 0.083 DBMET03332 0.199 0.113 DBMET03324 0.24 0.083 DBMET03333 0.24 0.083 DBMET03334 | DBMET03328 | |
| 0.103 | 0.113 | 0.132 | Interleukin 4 antagonist | 0.107 0.105 DBMET03325 0.132 0.069 DBMET03326 0.113 0.096 DBMET03328 0.115 0.093 DBMET03332 0.115 0.093 DBMET03333 0.115 0.093 DBMET03334 | DBMET03326 | |
| 0.049 | 0.059 | 0.077 | Neuraminidase inhibitor | 0.06 0.043 DBMET03325 0.068 0.035 DBMET03326 0.077 0.028 DBMET03328 0.061 0.042 DBMET03329 0.057 0.047 DBMET03332 0.057 0.047 DBMET03333 0.057 0.047 DBMET03334 | DBMET03328 | |
| 0.016 | 0.028 | 0.052 | Alpha 1a adrenoreceptor agonist | 0.052 0.005 DBMET03332 0.052 0.005 DBMET03333 0.052 0.005 DBMET03334 | DBMET03334 | |
| 0.093 | 0.106 | 0.141 | Nav1.3 sodium channel blocker | 0.141 0.054 DBMET03332 0.141 0.054 DBMET03333 0.141 0.054 DBMET03334 | DBMET03334 | |
| 0.041 | 0.055 | 0.09 | Factor IXa inhibitor | 0.073 0.019 DBMET03325 0.074 0.018 DBMET03326 0.071 0.02 DBMET03328 0.09 0.013 DBMET03332 0.072 0.019 DBMET03324 0.09 0.013 DBMET03333 0.09 0.013 DBMET03334 | DBMET03334 | |
| 0.201 | 0.22 | 0.585 | Alpha-glucosidase inhibitor | 0.448 0.097 DBMET03326 0.35 0.136 DBMET03328 0.585 0.057 DBMET03329 | DBMET03329 | |
| 0.153 | 0.172 | 0.416 | Cardiotonic | 0.416 0.026 DBMET03332 0.416 0.026 DBMET03333 0.416 0.026 DBMET03334 | DBMET03334 | |
| 0.085 | 0.104 | 0.093 | Nav1.4 sodium channel blocker | 0.093 0.088 DBMET03332 0.093 0.088 DBMET03333 0.093 0.088 DBMET03334 | DBMET03334 | |
| 0.01 | 0.034 | 0.016 | Adenosine A2 receptor agonist | 0.016 0.011 DBMET03332 0.016 0.011 DBMET03333 0.016 0.011 DBMET03334 | DBMET03334 | |
| 0.159 | 0.185 | 0.322 | Nitric-oxide synthase stimulant | 0.322 0.007 DBMET03332 0.322 0.007 DBMET03333 0.322 0.007 DBMET03334 | DBMET03334 | |
| 0.079 | 0.108 | 0.31 | Carbonic anhydrase XV inhibitor | 0.31 0.007 DBMET03332 0.31 0.007 DBMET03333 0.31 0.007 DBMET03334 | DBMET03334 | |
| 0.011 | 0.04 | 0.02 | Factor IX inhibitor | 0.02 0.012 DBMET03326 0.018 0.014 DBMET03332 0.018 0.014 DBMET03333 0.018 0.014 DBMET03334 | DBMET03326 | |
| 0.07 | 0.103 | 0.093 | Urease inhibitor | 0.093 0.075 DBMET03332 0.093 0.075 DBMET03333 0.093 0.075 DBMET03334 | DBMET03334 | |
| 0.076 | 0.111 | 0.217 | Toll-Like receptor 3 antagonist | 0.217 0.005 DBMET03332 0.217 0.005 DBMET03333 0.217 0.005 DBMET03334 | DBMET03334 | |
| 0.225 | 0.266 | 0.322 | 5 Hydroxytryptamine release inhibitor | 0.322 0.141 DBMET03332 0.322 0.141 DBMET03333 0.322 0.141 DBMET03334 | DBMET03334 | |
| 0.099 | 0.142 | 0.407 | Acetylcholine M1 receptor antagonist | 0.407 0.005 DBMET03332 0.407 0.005 DBMET03333 0.407 0.005 DBMET03334 | DBMET03334 | |
| 0.03 | 0.073 | 0.05 | Neuraminidase (Influenza A) inhibitor | 0.046 0.031 DBMET03326 0.05 0.025 DBMET03328 0.046 0.031 DBMET03329 0.047 0.029 DBMET03332 0.047 0.029 DBMET03333 0.047 0.029 DBMET03334 | DBMET03328 | |
| 0.055 | 0.098 | 0.106 | Somatostatin 1 agonist | 0.106 0.03 DBMET03332 0.106 0.03 DBMET03333 0.106 0.03 DBMET03334 | DBMET03334 | |
| 0.039 | 0.083 | 0.06 | Sphingosine kinase 2 inhibitor | 0.06 0.032 DBMET03332 0.06 0.032 DBMET03333 0.06 0.032 DBMET03334 | DBMET03334 | |
| 0.027 | 0.071 | 0.06 | NMDA receptor subunit 3B antagonist | 0.06 0.019 DBMET03332 0.06 0.019 DBMET03333 0.06 0.019 DBMET03334 | DBMET03334 | |
| 0.007 | 0.052 | 0.028 | Calcium-sensing receptor antagonist | 0.028 0.007 DBMET03332 0.028 0.007 DBMET03333 0.028 0.007 DBMET03334 | DBMET03334 | |
| 0.135 | 0.18 | 0.464 | Interleukin agonist | 0.214 0.108 DBMET03326 0.464 0.011 DBMET03332 0.464 0.011 DBMET03333 0.464 0.011 DBMET03334 | DBMET03334 | |
| 0.076 | 0.122 | 0.192 | Mucolytic | 0.192 0.015 DBMET03332 0.192 0.015 DBMET03333 0.192 0.015 DBMET03334 | DBMET03334 | |
| 0.025 | 0.071 | 0.043 | Membrane dipeptidase inhibitor | 0.043 0.023 DBMET03332 0.043 0.023 DBMET03333 0.043 0.023 DBMET03334 | DBMET03334 | |
| 0.162 | 0.211 | 0.431 | Transcription factor NF kappa B inhibitor | 0.186 0.184 DBMET03325 0.355 0.075 DBMET03326 0.265 0.117 DBMET03328 0.203 0.166 DBMET03329 0.431 0.057 DBMET03332 0.21 0.159 DBMET03324 0.431 0.057 DBMET03333 0.431 0.057 DBMET03334 | DBMET03334 | |
| 0.021 | 0.074 | 0.048 | Dopamine D2 agonist | 0.048 0.028 DBMET03332 0.048 0.028 DBMET03333 0.048 0.028 DBMET03334 | DBMET03334 | |
| 0.109 | 0.162 | 0.138 | Melanin inhibitor | 0.131 0.112 DBMET03326 0.138 0.101 DBMET03332 0.138 0.101 DBMET03333 0.138 0.101 DBMET03334 | DBMET03334 | |
| 0.069 | 0.122 | 0.167 | Carbonic anhydrase III inhibitor | 0.167 0.023 DBMET03332 0.167 0.023 DBMET03333 0.167 0.023 DBMET03334 | DBMET03334 | |
| 0.055 | 0.11 | 0.159 | Carbonic anhydrase VI inhibitor | 0.159 0.019 DBMET03332 0.159 0.019 DBMET03333 0.159 0.019 DBMET03334 | DBMET03334 | |
| 0.074 | 0.132 | 0.328 | Acetylcholine muscarinic antagonist | 0.328 0.007 DBMET03332 0.328 0.007 DBMET03333 0.328 0.007 DBMET03334 | DBMET03334 | |
| 0.016 | 0.078 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.016 DBMET03332 0.03 0.016 DBMET03333 0.03 0.016 DBMET03334 | DBMET03334 | |
| 0.094 | 0.157 | 0.125 | Protein-tyrosine phosphatase inhibitor | 0.118 0.116 DBMET03326 0.125 0.107 DBMET03329 | DBMET03329 | |
| 0.079 | 0.145 | 0.191 | M17 leucyl aminopeptidase inhibitor | 0.191 0.036 DBMET03324 | DBMET03324 | |
| 0.041 | 0.109 | 0.099 | Carbonic anhydrase XIII inhibitor | 0.099 0.038 DBMET03332 0.099 0.038 DBMET03333 0.099 0.038 DBMET03334 | DBMET03334 | |
| 0.016 | 0.086 | 0.034 | Thrombin receptor antagonist | 0.034 0.014 DBMET03332 0.034 0.014 DBMET03333 0.034 0.014 DBMET03334 | DBMET03334 | |
| 0.119 | 0.188 | 0.203 | Phospholipase C inhibitor | 0.203 0.042 DBMET03332 0.203 0.042 DBMET03333 0.203 0.042 DBMET03334 | DBMET03334 | |
| 0.057 | 0.128 | 0.086 | GABA B receptor agonist | 0.086 0.031 DBMET03332 0.086 0.031 DBMET03333 0.086 0.031 DBMET03334 | DBMET03334 | |
| 0.065 | 0.141 | 0.08 | Hematopoietic | 0.08 0.072 DBMET03332 0.08 0.072 DBMET03333 0.08 0.072 DBMET03334 | DBMET03334 | |
| 0.074 | 0.151 | 0.097 | Nav1.5 sodium channel blocker | 0.097 0.09 DBMET03332 0.097 0.09 DBMET03333 0.097 0.09 DBMET03334 | DBMET03334 | |
| 0.038 | 0.119 | 0.111 | NMDA receptor agonist | 0.111 0.015 DBMET03332 0.111 0.015 DBMET03333 0.111 0.015 DBMET03334 | DBMET03334 | |
| 0.025 | 0.106 | 0.062 | AICAR transformylase inhibitor | 0.062 0.013 DBMET03332 0.062 0.013 DBMET03333 0.062 0.013 DBMET03334 | DBMET03334 | |
| 0.011 | 0.093 | 0.025 | Neuraminidase (Influenza B) inhibitor | 0.025 0.007 DBMET03332 0.025 0.007 DBMET03333 0.025 0.007 DBMET03334 | DBMET03334 | |
| 0.035 | 0.118 | 0.053 | Vanilloid 2 antagonist | 0.053 0.034 DBMET03332 0.053 0.034 DBMET03333 0.053 0.034 DBMET03334 | DBMET03334 | |
| 0.062 | 0.145 | 0.415 | Anesthetic local | 0.415 0.006 DBMET03332 0.415 0.006 DBMET03333 0.415 0.006 DBMET03334 | DBMET03334 | |
| 0.016 | 0.099 | 0.081 | NMDA receptor subunit 3A antagonist | 0.081 0.011 DBMET03332 0.081 0.011 DBMET03333 0.081 0.011 DBMET03334 | DBMET03334 | |
| 0.034 | 0.123 | 0.066 | Alpha 1b adrenoreceptor agonist | 0.066 0.014 DBMET03332 0.066 0.014 DBMET03333 0.066 0.014 DBMET03334 | DBMET03334 | |
| 0.026 | 0.118 | 0.086 | Potassium channel (Inward rectifier) blocker | 0.086 0.01 DBMET03332 0.086 0.01 DBMET03333 0.086 0.01 DBMET03334 | DBMET03334 | |
| 0.083 | 0.176 | 0.138 | Transcription factor STAT6 inhibitor | 0.138 0.034 DBMET03332 0.138 0.034 DBMET03333 0.138 0.034 DBMET03334 | DBMET03334 | |
| 0.029 | 0.123 | 0.06 | NMDA 2B receptor antagonist | 0.06 0.031 DBMET03332 0.06 0.031 DBMET03333 0.06 0.031 DBMET03334 | DBMET03334 | |
| 0.014 | 0.11 | 0.044 | Melatonin 2 agonist | 0.044 0.013 DBMET03332 0.044 0.013 DBMET03333 0.044 0.013 DBMET03334 | DBMET03334 | |
| 0.163 | 0.263 | 0.242 | MAP kinase kinase 3 inhibitor | 0.242 0.04 DBMET03332 0.242 0.04 DBMET03333 0.242 0.04 DBMET03334 | DBMET03334 | |
| 0.14 | 0.24 | 0.311 | Cholesterol antagonist | 0.261 0.117 DBMET03325 0.311 0.084 DBMET03326 0.288 0.099 DBMET03328 0.253 0.123 DBMET03329 0.231 0.139 DBMET03332 0.231 0.139 DBMET03333 0.231 0.139 DBMET03334 | DBMET03326 | |
| 0.147 | 0.247 | 0.465 | Vasodilator, peripheral | 0.465 0.036 DBMET03332 0.465 0.036 DBMET03333 0.465 0.036 DBMET03334 | DBMET03334 | |
| 0.04 | 0.148 | 0.057 | Gonadotropin-releasing hormone receptor agonist | 0.057 0.047 DBMET03332 0.057 0.047 DBMET03333 0.057 0.047 DBMET03334 | DBMET03334 | |
| 0.012 | 0.122 | 0.043 | Vascular adhesion protein 1 inhibitor | 0.043 0.022 DBMET03332 0.043 0.022 DBMET03333 0.043 0.022 DBMET03334 | DBMET03334 | |
| 0.024 | 0.134 | 0.214 | Acetylcholine M5 receptor antagonist | 0.214 0.004 DBMET03332 0.214 0.004 DBMET03333 0.214 0.004 DBMET03334 | DBMET03334 | |
| 0.034 | 0.145 | 0.148 | Glutamate decarboxylase inhibitor | 0.148 0.013 DBMET03332 0.148 0.013 DBMET03333 0.148 0.013 DBMET03334 | DBMET03334 | |
| 0.01 | 0.123 | 0.049 | Carbonic anhydrase IV inhibitor | 0.049 0.025 DBMET03332 0.049 0.025 DBMET03333 0.049 0.025 DBMET03334 | DBMET03334 | |
| 0.048 | 0.175 | 0.184 | Expectorant | 0.089 0.082 DBMET03326 0.184 0.024 DBMET03332 0.184 0.024 DBMET03333 0.184 0.024 DBMET03334 | DBMET03334 | |
| 0.014 | 0.144 | 0.213 | NMDA 2A receptor antagonist | 0.213 0.004 DBMET03332 0.213 0.004 DBMET03333 0.213 0.004 DBMET03334 | DBMET03334 | |
| 0.065 | 0.2 | 0.12 | Electron transport complex I inhibitor | 0.12 0.047 DBMET03332 0.12 0.047 DBMET03333 0.12 0.047 DBMET03334 | DBMET03334 | |
| 0.019 | 0.155 | 0.05 | Antibiotic Aminoglycoside-like | 0.046 0.016 DBMET03325 0.05 0.013 DBMET03326 0.048 0.015 DBMET03328 0.047 0.015 DBMET03329 0.033 0.031 DBMET03324 | DBMET03326 | |
| 0.056 | 0.191 | 0.164 | AMP-activated protein kinase stimulant | 0.164 0.02 DBMET03326 0.118 0.051 DBMET03328 0.138 0.036 DBMET03329 | DBMET03326 | |
| 0.003 | 0.143 | 0.014 | Adenosine A2a receptor agonist | 0.014 0.011 DBMET03332 0.014 0.011 DBMET03333 0.014 0.011 DBMET03334 | DBMET03334 | |
| 0.018 | 0.162 | 0.213 | NMDA 2 receptor antagonist | 0.213 0.008 DBMET03332 0.213 0.008 DBMET03333 0.213 0.008 DBMET03334 | DBMET03334 | |
| 0.017 | 0.163 | 0.06 | Carbonic anhydrase XIV inhibitor | 0.06 0.025 DBMET03332 0.06 0.025 DBMET03333 0.06 0.025 DBMET03334 | DBMET03334 | |
| 0.025 | 0.173 | 0.287 | Alpha adrenoreceptor agonist | 0.287 0.005 DBMET03332 0.287 0.005 DBMET03333 0.287 0.005 DBMET03334 | DBMET03334 | |
| 0.047 | 0.198 | 0.205 | Ferrochelatase inhibitor | 0.205 0.021 DBMET03332 0.205 0.021 DBMET03333 0.205 0.021 DBMET03334 | DBMET03334 | |
| 0.019 | 0.172 | 0.072 | NMDA receptor glycine site agonist | 0.072 0.035 DBMET03332 0.072 0.035 DBMET03333 0.072 0.035 DBMET03334 | DBMET03334 | |
| 0.034 | 0.187 | 0.155 | Monophenol monooxygenase inhibitor | 0.155 0.045 DBMET03332 0.155 0.045 DBMET03333 0.155 0.045 DBMET03334 | DBMET03334 | |
| 0.033 | 0.187 | 0.217 | NMDA receptor antagonist | 0.217 0.012 DBMET03332 0.217 0.012 DBMET03333 0.217 0.012 DBMET03334 | DBMET03334 | |
| 0.03 | 0.185 | 0.081 | Purinergic P2X1 antagonist | 0.081 0.024 DBMET03332 0.081 0.024 DBMET03333 0.081 0.024 DBMET03334 | DBMET03334 | |
| 0.013 | 0.169 | 0.035 | Melatonin 1 agonist | 0.035 0.02 DBMET03332 0.035 0.02 DBMET03333 0.035 0.02 DBMET03334 | DBMET03334 | |
| 0.048 | 0.204 | 0.143 | Anabolic | 0.143 0.022 DBMET03332 0.143 0.022 DBMET03333 0.143 0.022 DBMET03334 | DBMET03334 | |
| 0.011 | 0.177 | 0.031 | Melatonin agonist | 0.031 0.025 DBMET03332 0.031 0.025 DBMET03333 0.031 0.025 DBMET03334 | DBMET03334 | |
| 0.125 | 0.291 | 0.472 | Vasodilator, coronary | 0.229 0.155 DBMET03326 0.223 0.161 DBMET03328 0.472 0.02 DBMET03332 0.472 0.02 DBMET03333 0.472 0.02 DBMET03334 | DBMET03334 | |
| 0.01 | 0.179 | 0.052 | Dihydropteroate synthase inhibitor | 0.052 0.016 DBMET03332 0.052 0.016 DBMET03333 0.052 0.016 DBMET03334 | DBMET03334 | |
| 0.064 | 0.233 | 0.162 | Neurotrophic factor | 0.114 0.106 DBMET03328 0.162 0.049 DBMET03329 0.128 0.084 DBMET03332 0.128 0.084 DBMET03333 0.128 0.084 DBMET03334 | DBMET03329 | |
| 0.016 | 0.187 | 0.161 | Acetylcholine M2 receptor antagonist | 0.161 0.01 DBMET03332 0.161 0.01 DBMET03333 0.161 0.01 DBMET03334 | DBMET03334 | |
| 0.049 | 0.225 | 0.302 | Acetylcholine antagonist | 0.302 0.014 DBMET03332 0.302 0.014 DBMET03333 0.302 0.014 DBMET03334 | DBMET03334 | |
| 0.012 | 0.192 | 0.051 | Prostaglandin EP2 antagonist | 0.051 0.05 DBMET03332 0.051 0.05 DBMET03333 0.051 0.05 DBMET03334 | DBMET03334 | |
| 0.06 | 0.241 | 0.138 | Acetylcholine release stimulant | 0.138 0.025 DBMET03332 0.138 0.025 DBMET03333 0.138 0.025 DBMET03334 | DBMET03334 | |
| 0.049 | 0.23 | 0.305 | Cholinergic antagonist | 0.305 0.014 DBMET03332 0.305 0.014 DBMET03333 0.305 0.014 DBMET03334 | DBMET03334 | |
| 0.021 | 0.205 | 0.049 | Leukotriene B4 antagonist | 0.049 0.047 DBMET03332 0.049 0.047 DBMET03333 0.049 0.047 DBMET03334 | DBMET03334 | |
| 0.032 | 0.216 | 0.103 | Interferon inducer | 0.103 0.011 DBMET03332 0.103 0.011 DBMET03333 0.103 0.011 DBMET03334 | DBMET03334 | |
| 0.06 | 0.251 | 0.416 | Peroxidase inhibitor | 0.416 0.018 DBMET03332 0.416 0.018 DBMET03333 0.416 0.018 DBMET03334 | DBMET03334 | |
| 0.042 | 0.234 | 0.188 | Alpha 2b adrenoreceptor antagonist | 0.188 0.027 DBMET03332 0.188 0.027 DBMET03333 0.188 0.027 DBMET03334 | DBMET03334 | |
| 0.055 | 0.25 | 0.121 | Glutamate (mGluR7) agonist | 0.121 0.03 DBMET03332 0.121 0.03 DBMET03333 0.121 0.03 DBMET03334 | DBMET03334 | |
| 0.12 | 0.319 | 0.215 | 15-Lipoxygenase inhibitor | 0.215 0.196 DBMET03332 0.215 0.196 DBMET03333 0.215 0.196 DBMET03334 | DBMET03334 | |
| 0.114 | 0.314 | 0.205 | Neuropeptide Y2 antagonist | 0.205 0.111 DBMET03332 0.205 0.111 DBMET03333 0.205 0.111 DBMET03334 | DBMET03334 | |
| 0.044 | 0.244 | 0.149 | Alkylator | 0.132 0.058 DBMET03326 0.123 0.066 DBMET03328 0.097 0.092 DBMET03329 0.129 0.06 DBMET03332 0.149 0.047 DBMET03324 0.129 0.06 DBMET03333 0.129 0.06 DBMET03334 | DBMET03324 | |
| 0.003 | 0.208 | 0.028 | Sigma 2 receptor antagonist | 0.028 0.018 DBMET03332 0.028 0.018 DBMET03333 0.028 0.018 DBMET03334 | DBMET03334 | |
| 0.004 | 0.209 | 0.044 | Alpha 2a adrenoreceptor agonist | 0.044 0.004 DBMET03332 0.044 0.004 DBMET03333 0.044 0.004 DBMET03334 | DBMET03334 | |
| 0.003 | 0.209 | 0.02 | Ileal bile acid transport inhibitor | 0.02 0.009 DBMET03332 0.02 0.009 DBMET03333 0.02 0.009 DBMET03334 | DBMET03334 | |
| 0.009 | 0.216 | 0.022 | Protein 30S ribosomal subunit inhibitor | 0.022 0.019 DBMET03326 0.022 0.02 DBMET03328 0.021 0.02 DBMET03329 | DBMET03328 | |
| 0.071 | 0.282 | 0.14 | Sphingosine 1-phosphate receptor 2 antagonist | 0.14 0.056 DBMET03332 0.14 0.056 DBMET03333 0.14 0.056 DBMET03334 | DBMET03334 | |
| 0.025 | 0.239 | 0.063 | Potassium channel (ATP-sensitive) blocker | 0.063 0.053 DBMET03332 0.063 0.053 DBMET03333 0.063 0.053 DBMET03334 | DBMET03334 | |
| 0.08 | 0.298 | 0.126 | Papain-like protease (SARS coronavirus) inhibitor | 0.126 0.069 DBMET03332 0.126 0.069 DBMET03333 0.126 0.069 DBMET03334 | DBMET03334 | |
| 0.016 | 0.234 | 0.213 | Selectin antagonist | 0.162 0.016 DBMET03325 0.213 0.01 DBMET03326 0.186 0.013 DBMET03328 0.179 0.014 DBMET03329 0.105 0.026 DBMET03324 | DBMET03326 | |
| 0.007 | 0.231 | 0.049 | Geranyltranstransferase inhibitor | 0.049 0.024 DBMET03332 0.049 0.024 DBMET03333 0.049 0.024 DBMET03334 | DBMET03334 | |
| 0.014 | 0.243 | 0.044 | Tryptophan 5 hydroxylase inhibitor | 0.044 0.01 DBMET03332 0.044 0.01 DBMET03333 0.044 0.01 DBMET03334 | DBMET03334 | |
| 0.009 | 0.239 | 0.062 | Alpha 1d adrenoreceptor agonist | 0.062 0.01 DBMET03332 0.062 0.01 DBMET03333 0.062 0.01 DBMET03334 | DBMET03334 | |
| 0.064 | 0.3 | 0.168 | Hypolipemic | 0.168 0.12 DBMET03328 | DBMET03328 | |
| 0.008 | 0.245 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.019 DBMET03332 0.029 0.019 DBMET03333 0.029 0.019 DBMET03334 | DBMET03334 | |
| 0.053 | 0.289 | 0.09 | T cell inhibitor | 0.09 0.039 DBMET03332 0.09 0.039 DBMET03333 0.09 0.039 DBMET03334 | DBMET03334 | |
| 0.006 | 0.243 | 0.024 | Estrogen-related receptor gamma agonist | 0.024 0.006 DBMET03332 0.024 0.006 DBMET03333 0.024 0.006 DBMET03334 | DBMET03334 | |
| 0.006 | 0.243 | 0.055 | Phosphoglycerate kinase inhibitor | 0.055 0.012 DBMET03332 0.055 0.012 DBMET03333 0.055 0.012 DBMET03334 | DBMET03334 | |
| 0.096 | 0.334 | 0.223 | DNA synthesis inhibitor | 0.204 0.117 DBMET03326 0.222 0.091 DBMET03328 0.223 0.09 DBMET03329 0.219 0.096 DBMET03332 0.173 0.164 DBMET03324 0.219 0.096 DBMET03333 0.219 0.096 DBMET03334 | DBMET03329 | |
| 0.028 | 0.269 | 0.133 | Interferon agonist | 0.133 0.013 DBMET03332 0.133 0.013 DBMET03333 0.133 0.013 DBMET03334 | DBMET03334 | |
| 0.049 | 0.292 | 0.183 | Cyclooxygenase 3 inhibitor | 0.102 0.1 DBMET03326 0.183 0.026 DBMET03332 0.183 0.026 DBMET03333 0.183 0.026 DBMET03334 | DBMET03334 | |
| 0.041 | 0.283 | 0.103 | DNA polymerase I inhibitor | 0.094 0.093 DBMET03326 0.099 0.087 DBMET03328 0.103 0.083 DBMET03332 0.103 0.083 DBMET03333 0.103 0.083 DBMET03334 | DBMET03334 | |
| 0.037 | 0.281 | 0.164 | Alpha 2c adrenoreceptor antagonist | 0.164 0.027 DBMET03332 0.164 0.027 DBMET03333 0.164 0.027 DBMET03334 | DBMET03334 | |
| 0.014 | 0.259 | 0.132 | Alpha 2 adrenoreceptor agonist | 0.132 0.008 DBMET03332 0.132 0.008 DBMET03333 0.132 0.008 DBMET03334 | DBMET03334 | |
| 0.011 | 0.256 | 0.067 | Mannosidase inhibitor | 0.067 0.013 DBMET03332 0.067 0.013 DBMET03333 0.067 0.013 DBMET03334 | DBMET03334 | |
| 0.022 | 0.268 | 0.09 | Aminopeptidase I inhibitor | 0.09 0.034 DBMET03332 0.09 0.034 DBMET03333 0.09 0.034 DBMET03334 | DBMET03334 | |
| 0.018 | 0.272 | 0.068 | Sphingosine 1-phosphate receptor 3 antagonist | 0.068 0.028 DBMET03332 0.068 0.028 DBMET03333 0.068 0.028 DBMET03334 | DBMET03334 | |
| 0.024 | 0.279 | 0.105 | Alpha 2 adrenoreceptor antagonist | 0.105 0.044 DBMET03332 0.105 0.044 DBMET03333 0.105 0.044 DBMET03334 | DBMET03334 | |
| 0.021 | 0.277 | 0.063 | Heparanase inhibitor | 0.063 0.019 DBMET03326 0.05 0.044 DBMET03328 0.056 0.03 DBMET03329 | DBMET03326 | |
| 0.033 | 0.294 | 0.202 | GABA C receptor agonist | 0.202 0.02 DBMET03332 0.202 0.02 DBMET03333 0.202 0.02 DBMET03334 | DBMET03334 | |
| 0.048 | 0.309 | 0.115 | Estrogen-related receptor beta agonist | 0.115 0.012 DBMET03332 0.115 0.012 DBMET03333 0.115 0.012 DBMET03334 | DBMET03334 | |
| 0.016 | 0.279 | 0.042 | Glutamate (mGluR8) agonist | 0.042 0.019 DBMET03332 0.042 0.019 DBMET03333 0.042 0.019 DBMET03334 | DBMET03334 | |
| 0.051 | 0.315 | 0.084 | Glutamate release inhibitor | 0.084 0.079 DBMET03332 0.084 0.079 DBMET03333 0.084 0.079 DBMET03334 | DBMET03334 | |
| 0.06 | 0.324 | 0.597 | Spasmolytic | 0.597 0.013 DBMET03332 0.597 0.013 DBMET03333 0.597 0.013 DBMET03334 | DBMET03334 | |
| 0.013 | 0.278 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | 0.056 0.027 DBMET03332 0.056 0.027 DBMET03333 0.056 0.027 DBMET03334 | DBMET03334 | |
| 0.024 | 0.29 | 0.138 | GABA aminotransferase inhibitor | 0.138 0.01 DBMET03332 0.138 0.01 DBMET03333 0.138 0.01 DBMET03334 | DBMET03334 | |
| 0.014 | 0.287 | 0.073 | Alpha-mannosidase inhibitor | 0.073 0.015 DBMET03332 0.073 0.015 DBMET03333 0.073 0.015 DBMET03334 | DBMET03334 | |
| 0.005 | 0.282 | 0.024 | Lysine carboxypeptidase inhibitor | 0.024 0.022 DBMET03332 0.024 0.022 DBMET03333 0.024 0.022 DBMET03334 | DBMET03334 | |
| 0.103 | 0.38 | 0.231 | Insulysin inhibitor | 0.231 0.115 DBMET03332 0.231 0.115 DBMET03333 0.231 0.115 DBMET03334 | DBMET03334 | |
| 0.007 | 0.286 | 0.049 | Ornithine carbamoyltransferase inhibitor | 0.049 0.04 DBMET03332 0.049 0.04 DBMET03333 0.049 0.04 DBMET03334 | DBMET03334 | |
| 0.071 | 0.35 | 0.194 | DNA damaging | 0.194 0.121 DBMET03329 | DBMET03329 | |
| 0.047 | 0.328 | 0.112 | Nav1.2 sodium channel blocker | 0.112 0.093 DBMET03332 0.112 0.093 DBMET03333 0.112 0.093 DBMET03334 | DBMET03334 | |
| 0.011 | 0.294 | 0.049 | Acyl-CoA dehydrogenase inhibitor | 0.049 0.044 DBMET03332 0.049 0.044 DBMET03333 0.049 0.044 DBMET03334 | DBMET03334 | |
| 0.065 | 0.349 | 0.279 | Vasodilator | 0.279 0.056 DBMET03332 0.279 0.056 DBMET03333 0.279 0.056 DBMET03334 | DBMET03334 | |
| 0.06 | 0.345 | 0.285 | Hepatoprotectant | 0.22 0.054 DBMET03325 0.266 0.039 DBMET03326 0.253 0.042 DBMET03328 0.285 0.034 DBMET03329 0.141 0.12 DBMET03324 | DBMET03329 | |
| 0.057 | 0.343 | 0.311 | Antiamyloidogenic | 0.311 0.048 DBMET03329 0.165 0.127 DBMET03332 0.165 0.127 DBMET03333 0.165 0.127 DBMET03334 | DBMET03329 | |
| 0.084 | 0.371 | 0.33 | Hypoxia-inducible factor 1 alpha inhibitor | 0.33 0.052 DBMET03332 0.33 0.052 DBMET03333 0.33 0.052 DBMET03334 | DBMET03334 | |
| 0.003 | 0.291 | 0.021 | Alpha 2c adrenoreceptor agonist | 0.021 0.01 DBMET03332 0.021 0.01 DBMET03333 0.021 0.01 DBMET03334 | DBMET03334 | |
| 0.012 | 0.3 | 0.161 | Alpha 1 adrenoreceptor agonist | 0.161 0.009 DBMET03332 0.161 0.009 DBMET03333 0.161 0.009 DBMET03334 | DBMET03334 | |
| 0.027 | 0.317 | 0.119 | Aminopeptidase B inhibitor | 0.119 0.053 DBMET03332 0.119 0.053 DBMET03333 0.119 0.053 DBMET03334 | DBMET03334 | |
| 0.027 | 0.317 | 0.069 | Glutamate dehydrogenase inhibitor | 0.069 0.058 DBMET03332 0.069 0.058 DBMET03333 0.069 0.058 DBMET03334 | DBMET03334 | |
| 0.008 | 0.3 | 0.119 | NMDA 2C receptor antagonist | 0.119 0.011 DBMET03332 0.119 0.011 DBMET03333 0.119 0.011 DBMET03334 | DBMET03334 | |
| 0.031 | 0.327 | 0.199 | HIV-1 integrase (Overall Integration) inhibitor | 0.199 0.012 DBMET03332 0.199 0.012 DBMET03333 0.199 0.012 DBMET03334 | DBMET03334 | |
| 0.019 | 0.318 | 0.054 | Botulinum neurotoxin type A inhibitor | 0.054 0.048 DBMET03332 0.054 0.048 DBMET03333 0.054 0.048 DBMET03334 | DBMET03334 | |
| 0.055 | 0.355 | 0.324 | Free radical scavenger | 0.217 0.085 DBMET03325 0.279 0.057 DBMET03326 0.289 0.055 DBMET03328 0.324 0.045 DBMET03329 0.248 0.069 DBMET03324 | DBMET03329 | |
| 0.067 | 0.368 | 0.257 | 5 Hydroxytryptamine 1E antagonist | 0.257 0.067 DBMET03332 0.257 0.067 DBMET03333 0.257 0.067 DBMET03334 | DBMET03334 | |
| 0.086 | 0.389 | 0.207 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.207 0.066 DBMET03332 0.207 0.066 DBMET03333 0.207 0.066 DBMET03334 | DBMET03334 | |
| 0.028 | 0.331 | 0.148 | Sphingomyelinase inhibitor | 0.148 0.025 DBMET03332 0.148 0.025 DBMET03333 0.148 0.025 DBMET03334 | DBMET03334 | |
| 0.018 | 0.322 | 0.085 | Epithelial sodium channel blocker | 0.085 0.011 DBMET03332 0.085 0.011 DBMET03333 0.085 0.011 DBMET03334 | DBMET03334 | |
| 0.02 | 0.324 | 0.093 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.093 0.02 DBMET03332 0.093 0.02 DBMET03333 0.093 0.02 DBMET03334 | DBMET03334 | |
| 0.011 | 0.321 | 0.041 | Microtubule stabilization | 0.041 0.04 DBMET03329 | DBMET03329 | |
| 0.082 | 0.397 | 0.145 | Neurotensin receptor agonist | 0.145 0.115 DBMET03332 0.145 0.115 DBMET03333 0.145 0.115 DBMET03334 | DBMET03334 | |
| 0.084 | 0.399 | 0.158 | Catenin beta inhibitor | 0.158 0.088 DBMET03324 | DBMET03324 | |
| 0.034 | 0.354 | 0.145 | Alpha-N-acetylglucosaminidase inhibitor | 0.145 0.058 DBMET03332 0.145 0.058 DBMET03333 0.145 0.058 DBMET03334 | DBMET03334 | |
| 0.01 | 0.334 | 0.042 | Histamine H1 receptor agonist | 0.042 0.034 DBMET03332 0.042 0.034 DBMET03333 0.042 0.034 DBMET03334 | DBMET03334 | |
| 0.038 | 0.364 | 0.177 | Anticoagulant | 0.177 0.062 DBMET03326 0.127 0.104 DBMET03328 0.175 0.063 DBMET03329 | DBMET03326 | |
| 0.01 | 0.339 | 0.039 | AMPA 4 receptor antagonist | 0.039 0.029 DBMET03332 0.039 0.029 DBMET03333 0.039 0.029 DBMET03334 | DBMET03334 | |
| 0.045 | 0.379 | 0.117 | Adenylate kinase inhibitor | 0.117 0.046 DBMET03332 0.117 0.046 DBMET03333 0.117 0.046 DBMET03334 | DBMET03334 | |
| 0.029 | 0.364 | 0.529 | Psychostimulant | 0.529 0.009 DBMET03332 0.529 0.009 DBMET03333 0.529 0.009 DBMET03334 | DBMET03334 | |
| 0.091 | 0.427 | 0.244 | Histamine release inhibitor | 0.244 0.16 DBMET03332 0.244 0.16 DBMET03333 0.244 0.16 DBMET03334 | DBMET03334 | |
| 0.006 | 0.347 | 0.029 | Acid ceramidase inhibitor | 0.029 0.011 DBMET03332 0.029 0.011 DBMET03333 0.029 0.011 DBMET03334 | DBMET03334 | |
| 0.039 | 0.381 | 0.091 | Transcription factor NF kappa B stimulant | 0.079 0.073 DBMET03325 0.089 0.052 DBMET03326 0.087 0.056 DBMET03328 0.091 0.05 DBMET03329 | DBMET03329 | |
| 0.013 | 0.357 | 0.08 | DNA gyrase inhibitor | 0.08 0.027 DBMET03326 | DBMET03326 | |
| 0.011 | 0.36 | 0.043 | Plasmepsin II inhibitor | 0.043 0.026 DBMET03332 0.043 0.026 DBMET03333 0.043 0.026 DBMET03334 | DBMET03334 | |
| 0.022 | 0.375 | 0.087 | Ornithine decarboxylase inhibitor | 0.087 0.06 DBMET03332 0.087 0.06 DBMET03333 0.087 0.06 DBMET03334 | DBMET03334 | |
| 0.064 | 0.423 | 0.413 | Immunosuppressant | 0.348 0.088 DBMET03326 0.383 0.071 DBMET03328 0.413 0.058 DBMET03329 0.239 0.157 DBMET03332 0.289 0.122 DBMET03324 0.239 0.157 DBMET03333 0.239 0.157 DBMET03334 | DBMET03329 | |
| 0.014 | 0.376 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.031 DBMET03332 0.041 0.031 DBMET03333 0.041 0.031 DBMET03334 | DBMET03334 | |
| 0.006 | 0.369 | 0.044 | Dopamine D5 agonist | 0.044 0.023 DBMET03332 0.044 0.023 DBMET03333 0.044 0.023 DBMET03334 | DBMET03334 | |
| 0.01 | 0.374 | 0.054 | Biliverdin reductase inhibitor | 0.054 0.048 DBMET03332 0.054 0.048 DBMET03333 0.054 0.048 DBMET03334 | DBMET03334 | |
| 0.016 | 0.385 | 0.077 | Alpha 2a adrenoreceptor antagonist | 0.077 0.051 DBMET03332 0.077 0.051 DBMET03333 0.077 0.051 DBMET03334 | DBMET03334 | |
| 0.022 | 0.393 | 0.126 | Topoisomerase II inhibitor | 0.121 0.066 DBMET03328 0.126 0.062 DBMET03329 | DBMET03329 | |
| 0.03 | 0.402 | 0.283 | Anesthetic general | 0.283 0.038 DBMET03332 0.283 0.038 DBMET03333 0.283 0.038 DBMET03334 | DBMET03334 | |
| 0.034 | 0.406 | 0.154 | Lanosterol 14 alpha demethylase inhibitor | 0.154 0.01 DBMET03332 0.154 0.01 DBMET03333 0.154 0.01 DBMET03334 | DBMET03334 | |
| 0.02 | 0.394 | 0.051 | Sodium/calcium exchanger inhibitor | 0.051 0.032 DBMET03332 0.051 0.032 DBMET03333 0.051 0.032 DBMET03334 | DBMET03334 | |
| 0.014 | 0.388 | 0.083 | Butyrylcholinesterase inhibitor | 0.083 0.079 DBMET03332 0.083 0.079 DBMET03333 0.083 0.079 DBMET03334 | DBMET03334 | |
| 0.011 | 0.393 | 0.075 | Adenylate cyclase 1 inhibitor | 0.075 0.01 DBMET03332 0.075 0.01 DBMET03333 0.075 0.01 DBMET03334 | DBMET03334 | |
| 0.035 | 0.424 | 0.288 | Immunostimulant | 0.176 0.135 DBMET03325 0.219 0.11 DBMET03326 0.222 0.108 DBMET03328 0.288 0.082 DBMET03329 0.254 0.094 DBMET03332 0.235 0.103 DBMET03324 0.254 0.094 DBMET03333 0.254 0.094 DBMET03334 | DBMET03329 | |
| 0.037 | 0.435 | 0.081 | D-Ala-D-Ala ligase inhibitor | 0.081 0.065 DBMET03332 0.081 0.065 DBMET03333 0.081 0.065 DBMET03334 | DBMET03334 | |
| 0.045 | 0.443 | 0.329 | Antioxidant | 0.222 0.1 DBMET03325 0.284 0.068 DBMET03326 0.329 0.052 DBMET03328 0.319 0.055 DBMET03329 0.238 0.091 DBMET03324 | DBMET03328 | |
| 0.041 | 0.455 | 0.146 | Hemostatic | 0.146 0.074 DBMET03332 0.146 0.074 DBMET03333 0.146 0.074 DBMET03334 | DBMET03334 | |
| 0.029 | 0.443 | 0.132 | Phospholipase A2 inhibitor | 0.132 0.097 DBMET03332 0.132 0.097 DBMET03333 0.132 0.097 DBMET03334 | DBMET03334 | |
| 0.004 | 0.419 | 0.04 | Oleamide hydrolase inhibitor | 0.04 0.037 DBMET03332 0.04 0.037 DBMET03333 0.04 0.037 DBMET03334 | DBMET03334 | |
| 0.074 | 0.49 | 0.206 | Sodium/bile acid cotransporter inhibitor | 0.206 0.18 DBMET03332 0.206 0.18 DBMET03333 0.206 0.18 DBMET03334 | DBMET03334 | |
| 0.012 | 0.431 | 0.148 | Analgesic, opioid | 0.148 0.015 DBMET03325 | DBMET03325 | |
| 0.063 | 0.485 | 0.18 | Gastrin inhibitor | 0.18 0.179 DBMET03332 0.18 0.179 DBMET03333 0.18 0.179 DBMET03334 | DBMET03334 | |
| 0.011 | 0.44 | 0.056 | Protein 50S ribosomal subunit inhibitor | 0.056 0.034 DBMET03326 0.054 0.036 DBMET03328 0.049 0.041 DBMET03329 | DBMET03326 | |
| 0.005 | 0.435 | 0.053 | Opioid agonist | 0.053 0.036 DBMET03325 | DBMET03325 | |
| 0.012 | 0.445 | 0.105 | Alpha adrenoreceptor antagonist | 0.105 0.054 DBMET03332 0.105 0.054 DBMET03333 0.105 0.054 DBMET03334 | DBMET03334 | |
| 0.025 | 0.468 | 0.084 | Triose-phosphate isomerase inhibitor | 0.084 0.068 DBMET03332 0.084 0.068 DBMET03333 0.084 0.068 DBMET03334 | DBMET03334 | |
| 0.064 | 0.507 | 0.272 | Immunomodulator | 0.272 0.099 DBMET03326 | DBMET03326 | |
| 0.027 | 0.472 | 0.091 | NADH dehydrogenase inhibitor | 0.091 0.055 DBMET03332 0.091 0.055 DBMET03333 0.091 0.055 DBMET03334 | DBMET03334 | |
| 0.03 | 0.476 | 0.108 | Cell adhesion inhibitor | 0.102 0.086 DBMET03326 0.103 0.084 DBMET03328 0.108 0.077 DBMET03329 | DBMET03329 | |
| 0.005 | 0.46 | 0.171 | Opioid kappa receptor agonist | 0.171 0.005 DBMET03325 | DBMET03325 | |
| 0.048 | 0.504 | 0.212 | Neurotrophic factor enhancer | 0.212 0.065 DBMET03332 0.212 0.065 DBMET03333 0.212 0.065 DBMET03334 | DBMET03334 | |
| 0.017 | 0.495 | 0.046 | Heme oxygenase inhibitor | 0.046 0.02 DBMET03332 0.046 0.02 DBMET03333 0.046 0.02 DBMET03334 | DBMET03334 | |
| 0.015 | 0.496 | 0.085 | Histamine N-methyltransferase inhibitor | 0.085 0.061 DBMET03332 0.085 0.061 DBMET03333 0.085 0.061 DBMET03334 | DBMET03334 | |
| 0.012 | 0.494 | 0.105 | Calcium antagonist | 0.105 0.044 DBMET03332 0.105 0.044 DBMET03333 0.105 0.044 DBMET03334 | DBMET03334 | |
| 0.014 | 0.498 | 0.098 | Falcipain 3 inhibitor | 0.098 0.072 DBMET03332 0.098 0.072 DBMET03333 0.098 0.072 DBMET03334 | DBMET03334 | |
| 0.014 | 0.503 | 0.105 | Cholesterol synthesis inhibitor | 0.105 0.081 DBMET03332 0.105 0.081 DBMET03333 0.105 0.081 DBMET03334 | DBMET03334 | |
| 0.095 | 0.589 | 0.184 | 5 Hydroxytryptamine 3E antagonist | 0.184 0.096 DBMET03332 0.184 0.096 DBMET03333 0.184 0.096 DBMET03334 | DBMET03334 | |
| 0.025 | 0.527 | 0.225 | Platelet antagonist | 0.202 0.1 DBMET03326 0.154 0.14 DBMET03328 0.225 0.085 DBMET03329 | DBMET03329 | |
| 0.015 | 0.522 | 0.112 | Myeloperoxidase inhibitor | 0.112 0.024 DBMET03332 0.112 0.024 DBMET03333 0.112 0.024 DBMET03334 | DBMET03334 | |
| 0.074 | 0.589 | 0.253 | Tyrosine 3 hydroxylase inhibitor | 0.253 0.065 DBMET03332 0.253 0.065 DBMET03333 0.253 0.065 DBMET03334 | DBMET03334 | |
| 0.061 | 0.581 | 0.508 | 5 Hydroxytryptamine release stimulant | 0.508 0.026 DBMET03332 0.508 0.026 DBMET03333 0.508 0.026 DBMET03334 | DBMET03334 | |
| 0.018 | 0.543 | 0.124 | GABA C receptor rho-1 antagonist | 0.124 0.037 DBMET03332 0.124 0.037 DBMET03333 0.124 0.037 DBMET03334 | DBMET03334 | |
| 0.004 | 0.529 | 0.068 | Antineoplastic antibiotic | 0.068 0.067 DBMET03326 0.068 0.066 DBMET03328 | DBMET03328 | |
| 0.004 | 0.532 | 0.068 | Alpha 1b adrenoreceptor antagonist | 0.068 0.054 DBMET03332 0.068 0.054 DBMET03333 0.068 0.054 DBMET03334 | DBMET03334 | |
| 0.014 | 0.546 | 0.061 | Ryanodine receptor antagonist | 0.061 0.036 DBMET03332 0.061 0.036 DBMET03333 0.061 0.036 DBMET03334 | DBMET03334 | |
| 0.03 | 0.564 | 0.184 | Interleukin 6 antagonist | 0.184 0.051 DBMET03332 0.184 0.051 DBMET03333 0.184 0.051 DBMET03334 | DBMET03334 | |
| 0.027 | 0.561 | 0.091 | Phosphodiesterase 6D inhibitor | 0.091 0.073 DBMET03332 0.091 0.073 DBMET03333 0.091 0.073 DBMET03334 | DBMET03334 | |
| 0.017 | 0.553 | 0.131 | Thrombolytic | 0.131 0.098 DBMET03326 | DBMET03326 | |
| 0.041 | 0.589 | 0.225 | Superoxide dismutase inhibitor | 0.225 0.093 DBMET03332 0.225 0.093 DBMET03333 0.225 0.093 DBMET03334 | DBMET03334 | |
| 0.037 | 0.587 | 0.313 | Antithrombotic | 0.195 0.183 DBMET03326 0.249 0.127 DBMET03328 0.313 0.08 DBMET03329 0.233 0.14 DBMET03332 0.233 0.14 DBMET03333 0.233 0.14 DBMET03334 | DBMET03329 | |
| 0.083 | 0.638 | 0.24 | 5 Hydroxytryptamine uptake stimulant | 0.24 0.091 DBMET03332 0.24 0.091 DBMET03333 0.24 0.091 DBMET03334 | DBMET03334 | |
| 0.051 | 0.607 | 0.246 | Lipocortins synthesis antagonist | 0.246 0.035 DBMET03332 0.246 0.035 DBMET03333 0.246 0.035 DBMET03334 | DBMET03334 | |
| 0.025 | 0.581 | 0.135 | Neuropeptide Y1 antagonist | 0.135 0.09 DBMET03332 0.135 0.09 DBMET03333 0.135 0.09 DBMET03334 | DBMET03334 | |
| 0.019 | 0.589 | 0.441 | Angiogenesis stimulant | 0.441 0.016 DBMET03325 0.371 0.027 DBMET03326 0.356 0.031 DBMET03328 0.367 0.028 DBMET03329 0.175 0.108 DBMET03324 | DBMET03325 | |
| 0.046 | 0.623 | 0.27 | Analgesic | 0.27 0.166 DBMET03325 | DBMET03325 | |
| 0.064 | 0.641 | 0.133 | Ca2+-transporting ATPase inhibitor | 0.133 0.103 DBMET03332 0.133 0.103 DBMET03333 0.133 0.103 DBMET03334 | DBMET03334 | |
| 0.022 | 0.623 | 0.166 | Nitric oxide antagonist | 0.131 0.118 DBMET03325 0.162 0.086 DBMET03326 0.165 0.084 DBMET03328 0.166 0.084 DBMET03329 | DBMET03329 | |
| 0.028 | 0.639 | 0.202 | Angiogenesis inhibitor | 0.202 0.167 DBMET03329 | DBMET03329 | |
| 0.01 | 0.643 | 0.127 | GABA C receptor antagonist | 0.127 0.046 DBMET03332 0.127 0.046 DBMET03333 0.127 0.046 DBMET03334 | DBMET03334 | |
| 0.045 | 0.679 | 0.303 | GABA C receptor rho-3 antagonist | 0.303 0.114 DBMET03332 0.303 0.114 DBMET03333 0.303 0.114 DBMET03334 | DBMET03334 | |
| 0.022 | 0.671 | 0.136 | GABA C receptor rho-2 antagonist | 0.136 0.094 DBMET03332 0.136 0.094 DBMET03333 0.136 0.094 DBMET03334 | DBMET03334 | |
| 0.013 | 0.683 | 0.126 | Cathepsin H inhibitor | 0.126 0.068 DBMET03332 0.126 0.068 DBMET03333 0.126 0.068 DBMET03334 | DBMET03334 | |
| 0.019 | 0.698 | 0.189 | Cyclic AMP phosphodiesterase inhibitor | 0.189 0.103 DBMET03332 0.189 0.103 DBMET03333 0.189 0.103 DBMET03334 | DBMET03334 | |
| 0.019 | 0.727 | 0.144 | Platelet adhesion inhibitor | 0.144 0.113 DBMET03326 0.14 0.118 DBMET03328 0.143 0.115 DBMET03329 | DBMET03326 | |
| 0.018 | 0.741 | 0.09 | Toll-Like receptor 4 antagonist | 0.09 0.089 DBMET03326 | DBMET03326 | |
| 0.034 | 0.77 | 0.253 | Apoptosis antagonist | 0.208 0.169 DBMET03326 0.238 0.139 DBMET03328 0.253 0.125 DBMET03329 | DBMET03329 | |
| 0.013 | 0.857 | 0.288 | Apoptosis agonist | 0.238 0.228 DBMET03326 0.239 0.227 DBMET03328 0.288 0.181 DBMET03329 | DBMET03329 | |
| 0.011 | 0.893 | 0.308 | Antiinflammatory | 0.308 0.208 DBMET03326 0.3 0.216 DBMET03328 | DBMET03326 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |